100 related articles for article (PubMed ID: 15191720)
1. [Antibody production and its neutralization of Abeta42's cytoxicity in BALB/c mice induced by Abeta42 and its subunit vaccines].
Hu JJ; Wang HQ; Qu HG; Xu J; Yao ZB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):178-81. PubMed ID: 15191720
[TBL] [Abstract][Full Text] [Related]
2. Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1-40.
Feng G; Wang W; Qian Y; Jin H
J Neurosci Methods; 2013 Aug; 218(1):48-54. PubMed ID: 23701997
[TBL] [Abstract][Full Text] [Related]
3. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
4. Norovirus P particle: an excellent vaccine platform for antibody production against Alzheimer's disease.
Fu L; Li Y; Hu Y; Yu B; Zhang H; Wu J; Wu H; Yu X; Kong W
Immunol Lett; 2015 Nov; 168(1):22-30. PubMed ID: 26349054
[TBL] [Abstract][Full Text] [Related]
5. Identification of the shortest Aβ-peptide generating highly specific antibodies against the C-terminal end of amyloid-β42.
Axelsen TV; Holm A; Christiansen G; Birkelund S
Vaccine; 2011 Apr; 29(17):3260-9. PubMed ID: 21371581
[TBL] [Abstract][Full Text] [Related]
6. Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice.
Xing XN; Zhang WG; Sha S; Li Y; Guo R; Wang C; Cao YP
Chin Med J (Engl); 2011 Sep; 124(17):2636-41. PubMed ID: 22040416
[TBL] [Abstract][Full Text] [Related]
7. Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice.
Li Q; Cao C; Chackerian B; Schiller J; Gordon M; Ugen KE; Morgan D
BMC Neurosci; 2004 Jun; 5():21. PubMed ID: 15186505
[TBL] [Abstract][Full Text] [Related]
8. Improvement of a low pH antigen-antibody dissociation procedure for ELISA measurement of circulating anti-Abeta antibodies.
Li Q; Gordon M; Cao C; Ugen KE; Morgan D
BMC Neurosci; 2007 Mar; 8():22. PubMed ID: 17374155
[TBL] [Abstract][Full Text] [Related]
9. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
[TBL] [Abstract][Full Text] [Related]
10. Effects of epitopes combination and adjuvants on immune responses to anti-Alzheimer disease DNA vaccines in mice.
He Y; Sun SH; Chen RW; Guo YJ; He XW; Huang L; Chen ZH; Shi K; Zhu WJ
Alzheimer Dis Assoc Disord; 2005; 19(4):171-7. PubMed ID: 16327342
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neurotoxicity of different aggregated forms of Aβ40, Aβ42 and Aβ43 in cell cultures.
Fu L; Sun Y; Guo Y; Chen Y; Yu B; Zhang H; Wu J; Yu X; Kong W; Wu H
J Pept Sci; 2017 Mar; 23(3):245-251. PubMed ID: 28211253
[TBL] [Abstract][Full Text] [Related]
12. [Specific humoral immune response in Rhesus monkeys vaccinated immune response with Abeta42 peptide vaccine].
Li SB; Wang HQ; Lin X; Xu J; Yao ZB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):202-4. PubMed ID: 15766406
[TBL] [Abstract][Full Text] [Related]
13. A mimotope peptide of Aβ42 fibril-specific antibodies with Aβ42 fibrillation inhibitory activity induces anti-Aβ42 conformer antibody response by a displayed form on an M13 phage in mice.
Tanaka K; Nishimura M; Yamaguchi Y; Hashiguchi S; Takiguchi S; Yamaguchi M; Tahara H; Gotanda T; Abe R; Ito Y; Sugimura K
J Neuroimmunol; 2011 Jul; 236(1-2):27-38. PubMed ID: 21641049
[TBL] [Abstract][Full Text] [Related]
14. Antibodies bound to Aβ oligomers potentiate the neurotoxicity of Aβ by activating microglia.
Morkuniene R; Zvirbliene A; Dalgediene I; Cizas P; Jankeviciute S; Baliutyte G; Jokubka R; Jankunec M; Valincius G; Borutaite V
J Neurochem; 2013 Sep; 126(5):604-15. PubMed ID: 23745639
[TBL] [Abstract][Full Text] [Related]
15. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.
Valensi JP; Carlson JR; Van Nest GA
J Immunol; 1994 Nov; 153(9):4029-39. PubMed ID: 7930610
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.
Lambert MP; Viola KL; Chromy BA; Chang L; Morgan TE; Yu J; Venton DL; Krafft GA; Finch CE; Klein WL
J Neurochem; 2001 Nov; 79(3):595-605. PubMed ID: 11701763
[TBL] [Abstract][Full Text] [Related]
17. DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
Lambracht-Washington D; Qu BX; Fu M; Eagar TN; Stüve O; Rosenberg RN
JAMA; 2009 Oct; 302(16):1796-802. PubMed ID: 19861672
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.
Ren ST; Zhang XM; Sun PF; Sun LJ; Guo X; Tian T; Zhang J; Guo QY; Li X; Guo LJ; Che J; Wang B; Zhang H
PLoS One; 2017; 12(1):e0169501. PubMed ID: 28052136
[TBL] [Abstract][Full Text] [Related]
19. The Peptide Vaccine Combined with Prior Immunization of a Conventional Diphtheria-Tetanus Toxoid Vaccine Induced Amyloid β Binding Antibodies on Cynomolgus Monkeys and Guinea Pigs.
Yano A; Ito K; Miwa Y; Kanazawa Y; Chiba A; Iigo Y; Kashimoto Y; Kanda A; Murata S; Makino M
J Immunol Res; 2015; 2015():786501. PubMed ID: 26539559
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
Kim HD; Jin JJ; Maxwell JA; Fukuchi K
Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
